Clinical Trial Update: Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma [Phase 1]

View source ↗

Summary

This Phase 1 trial studied the combination of trametinib and ceritinib in patients with unresectable or advanced melanoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Ceritinib (ceritinib)
• Trametinib (trametinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma, Unresectable Melanoma | Phase 1 | Status: COMPLETED